FindTrial
Sign In

Real world registration of accurate medical treatment based on noninvasive hemodynamic measurement of thoracic impedance in patients with hypertension

Real world registration of accurate medical treatment based on noninvasive hemodynamic measurement of thoracic impedance in patients with hypertension

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100051212
Enrollment
Unknown
Registered
2021-09-16
Start date
2021-12-01
Completion date
Unknown
Last updated
2022-05-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertension

Interventions

Observation group:During outpatient or admission, noninvasive hemodynamic test shall be carried out, the test results and drug use shall be recorded, and targeted antihypertensive drugs shall be used

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. All patients meet the diagnostic criteria for essential hypertension; in the absence of antihypertensive drugs, the office blood pressure was measured three times on different days, SBP>=140 mmHg and (or) DBP>=90 mmHg. SBP >= 140 mmHg and DBP < 90 mmHg; 2. Patients can communicate and communicate well with medical staff; 3. Aged 18-85 years.

Exclusion criteria

Exclusion criteria: 1. Pregnant or lactating women; 2. Other situations that are not suitable for testing.

Design outcomes

Primary

MeasureTime frame
blood pressure;heart rate index;system resistance;Vascular volume;—

Secondary

MeasureTime frame
blood fat;—

Countries

China

Contacts

Public ContactYang Jiefu

Beijing Hospital

yangjiefu2011@126.com+86 13601292259

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026